FUCA1
Tissue alpha-L-fucosidase
Also known as: FUCO_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04066
- Gene
- FUCA1
- Ensembl
- ENSG00000179163
- Chromosome
- 1
- Canonical length
- 466 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins
- Subcellular location
- Vesicles
- Secretome location
- Intracellular and membrane
- Quaternary structure
- Homotetramer
OverviewNCBI Gene
The protein encoded by this gene is a lysosomal enzyme involved in the degradation of fucose-containing glycoproteins and glycolipids. Mutations in this gene are associated with fucosidosis (FUCA1D), which is an autosomal recessive lysosomal storage disease. A pseudogene of this locus is present on chr 2.[provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
466 residues, UniProt reviewed canonical sequence.
>P04066|FUCA1
1 MRAPGMRSRP AGPALLLLLL FLGAAESVRR AQPPRRYTPD WPSLDSRPLP AWFDEAKFGV
61 FIHWGVFSVP AWGSEWFWWH WQGEGRPQYQ RFMRDNYPPG FSYADFGPQF TARFFHPEEW
121 ADLFQAAGAK YVVLTTKHHE GFTNWPSPVS WNWNSKDVGP HRDLVGELGT ALRKRNIRYG
181 LYHSLLEWFH PLYLLDKKNG FKTQHFVSAK TMPELYDLVN SYKPDLIWSD GEWECPDTYW
241 NSTNFLSWLY NDSPVKDEVV VNDRWGQNCS CHHGGYYNCE DKFKPQSLPD HKWEMCTSID
301 KFSWGYRRDM ALSDVTEESE IISELVQTVS LGGNYLLNIG PTKDGLIVPI FQERLLAVGK
361 WLSINGEAIY ASKPWRVQWE KNTTSVWYTS KGSAVYAIFL HWPENGVLNL ESPITTSTTK
421 ITMLGIQGDL KWSTDPDKGL FISLPQLPPS AVPAEFAWTI KLTGVKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FUCA1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 157 nTPM
Expression across tissuesHPA
Tissue
- lymph node: 157 nTPM
- rectum: 132 nTPM
- colon: 116 nTPM
- epididymis: 107 nTPM
- liver: 98 nTPM
- tonsil: 88 nTPM
Single-cell type
- syncytiotrophoblasts: 251 nCPM
- kupffer cells: 250 nCPM
- cytotrophoblasts: 241 nCPM
- enterocytes: 209 nCPM
- colonocytes: 188 nCPM
- hofbauer cells: 180 nCPM
Immune cell
- classical monocyte: 101 nTPM
- intermediate monocyte: 100 nTPM
- non-classical monocyte: 92 nTPM
- total PBMC: 65 nTPM
- basophil: 55 nTPM
- eosinophil: 52 nTPM
Brain region
- choroid plexus: 42 nTPM
- white matter: 18 nTPM
- thalamus: 15 nTPM
- hypothalamus: 13 nTPM
- pons: 12 nTPM
- medulla oblongata: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about FUCA1.
Disease | AllUniProt
Conditions FUCA1 is implicated in, by any mechanism.
- Fucosidosis (FUCA1D) MIM:230000
Disease | GeneticClinVar
88 pathogenic / likely-pathogenic of 499 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Fucosidosis
- FUCA1-related disorder
- Intellectual disability
- Abnormality of the nervous system
- Inborn genetic diseases
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.94
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.85
- DepMap mean gene effect
- -0.13
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FUCA1 as an antibody target. Whether an autoantibody or antibody against FUCA1 could matter depends on whether native FUCA1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FUCA1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label FUCA1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...